Use of hydroxyurea in French-speaking Sub-Saharan Africa

The hydroxyurea is a save, affordable and essential medicine for sickle cell disease (SCD), reducing painful crises and mortality. To foster the prescription of hydroxyurea for patients with SCD in sub-Saharan African countries, the scientific advisory board of Drep.Afrique, a non-governmental organization dedicated to SCD in Africa, has developed a therapeutic guideline well suited to conditions on the ground. These guidelines answer three essential questions: which patients should be prioritized for treatment with hydroxyurea, which dose should be used, and what follow-up should be implemented in those low-resources countries? The guidelines are given as in a concise document for easy use by practitioners on the ground, available in English and in French.

Authors

Institutions

Publication Details

Journal
Annals of Hematology
Published
2025-02-01
DOI
https://doi.org/10.1007/s00277-024-06180-2
Citations
3
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
4.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of hydroxyurea in French-speaking Sub-Saharan Africa

Mariane de Montalembert, Frédéric Galactéros, Ibrahima Diagne, Léon Tshilolo et al.
3 citations
Annals of Hematology
Hemoglobinopathies and Related Disorders
4.88
article

Use of hydroxyurea in French-speaking Sub-Saharan Africa

Mariane de Montalembert, Frédéric Galactéros, Ibrahima Diagne, Léon Tshilolo, Françoise Bernaudin, Anne Corbasson, Saliou Diop, Olivier Hermine, Charlotte Eposse, Brigitte Ranque, Éléonore Kafando, C. Vodouhé, Ahoéfa Vovor, Dapa A. Diallo, Indou Dème-Ly, J Arlet, Agnès Lainé, Binta Coulibaly
article en
3 citations

Abstract

The hydroxyurea is a save, affordable and essential medicine for sickle cell disease (SCD), reducing painful crises and mortality. To foster the prescription of hydroxyurea for patients with SCD in sub-Saharan African countries, the scientific advisory board of Drep.Afrique, a non-governmental organization dedicated to SCD in Africa, has developed a therapeutic guideline well suited to conditions on the ground. These guidelines answer three essential questions: which patients should be prioritized for treatment with hydroxyurea, which dose should be used, and what follow-up should be implemented in those low-resources countries? The guidelines are given as in a concise document for easy use by practitioners on the ground, available in English and in French.

Annals of HematologyVol. 104(2)
Université Gaston Berger (SN), Hôpital Necker-Enfants Malades (FR), Université Joseph Ki-Zerbo (BF), University of Douala (CM), Université Paris Cité (FR), Kinshasa General Hospital (CD), Institut des Mondes Africains (FR), University of Bamako (ML), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Européen Georges-Pompidou (FR), Centro Universitário de Franca (BR), Université des Sciences, des Techniques et des Technologies de Bamako (ML), Centre Hospitalier National Universitaire de Fann (SN), Hôpital Intercommunal de Créteil (FR), University of Lomé (TG), Cheikh Anta Diop University (SN)
Openalex Percentile: Top 6%
Hemoglobinopathies and Related Disorders
4.88
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.